Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.
J A Carew, … , J H Stoddart, D C Lynch
J A Carew, … , J H Stoddart, D C Lynch
Published December 1, 1992
Citation Information: J Clin Invest. 1992;90(6):2258-2267. https://doi.org/10.1172/JCI116112.
View: Text | PDF
Research Article Article has an altmetric score of 3

O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.

  • Text
  • PDF
Abstract

By transfecting the full-length cDNA for human von Willebrand factor (vWf) into a line of Chinese hamster ovary cells with a defect in carbohydrate metabolism, we have prepared recombinant vWf specifically lacking O-linked carbohydrates. We have compared this under-glycosylated protein to fully glycosylated recombinant vWf with respect to several structural and binding properties. vWf deficient in O-linked glycans was synthesized, assembled into multimers, and secreted in an apparently normal manner and was not prone to degradation in the extracellular milieu. It did not differ from fully glycosylated vWf in ability to bind to heparin or to collagen type I but did interact less well with glycoprotein 1b on formalin-fixed platelets. This decreased interaction was evidenced in both a lessened overall binding to platelets and in diminished capacity to promote platelet agglutination, in the presence of ristocetin. In contrast, no difference was seen in platelet binding in the presence of botrocetin. These data indicate a possible role for O-linked carbohydrates in the vWf-glycoprotein 1b interaction promoted by ristocetin and suggest that abnormalities in carbohydrate modification might contribute to the altered ristocetin-dependent reactivity between vWf and platelets described for some variant forms of von Willebrand disease.

Authors

J A Carew, S M Quinn, J H Stoddart, D C Lynch

×

Total citations by year

Year: 2024 2021 2019 2017 2015 2014 2012 2011 2010 2008 2006 2005 2003 2002 2000 1999 1996 1995 1994 1993 Total
Citations: 1 1 2 2 1 1 4 2 3 1 2 4 1 1 2 1 2 1 1 1 34
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (34)

Title and authors Publication Year
O-glycan determinants regulate VWF trafficking to Weibel-Palade bodies
Karampini E, Doherty D, Bürgisser PE, Garre M, Schoen I, Elliott S, Bierings R, O\u2019Donnell JS
Blood Advances 2024
The Biological Significance of von Willebrand Factor O-Linked Glycosylation
S Ward, JM O'Sullivan, JS O'Donnell
Seminars in thrombosis and hemostasis 2021
Synthetic glycopolymers and natural fucoidans cause human platelet aggregation via PEAR1 and GPIbα
C Kardeby, K Fälker, EJ Haining, M Criel, M Lindkvist, R Barroso, P Påhlsson, LU Ljungberg, M Tengdelius, GE Rainger, S Watson, JA Eble, MF Hoylaerts, J Emsley, P Konradsson, SP Watson, Y Sun, M Grenegård
Blood Advances 2019
Biologic roles of the ABH and Lewis histo‐blood group antigens part II: thrombosis, cardiovascular disease and metabolism
SR Stowell, CP Stowell
Vox Sanguinis 2019
Patterns and levels of platelet glycosylation in patients with coronary heart disease and type 2 diabetes mellitus
L Li, C Qu, X Wu, J Dai, Y Lu, Y Gong, R You, Y Liu
Journal of Thrombosis and Thrombolysis 2017
Mutant botrocetin-2 inhibits von Willebrand factor-induced platelet agglutination
T Matsui, A Hori, J Hamako, F Matsushita, Y Ozeki, Y Sakurai, M Hayakawa, M Matsumoto, Y Fujimura
Journal of Thrombosis and Haemostasis 2017
Quantitative Influence of ABO Blood Groups on Factor VIII and Its Ratio to von Willebrand Factor, Novel Observations from an ARIC Study of 11,673 Subjects
J Song, F Chen, M Campos, D Bolgiano, K Houck, LE Chambless, KK Wu, AR Folsom, D Couper, E Boerwinkle, J Dong, T Miyata
PloS one 2015
von Willebrand factor, Jedi knight of the bloodstream
TA Springer
Blood 2014
Platelet biogenesis and functions require correct protein O-glycosylation
Y Wang, SM Jobe, X Ding, H Choo, DR Archer, R Mi, T Ju, RD Cummings
Proceedings of the National Academy of Sciences 2012
Structure and function of von Willebrand factor :
MI Hassan, A Saxena, F Ahmad
Blood Coagulation & Fibrinolysis 2012
O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions
AA Nowak, K Canis, A Riddell, MA Laffan, TA McKinnon
Blood 2012
In Vivo Analysis of the Role of O-Glycosylations of Von Willebrand Factor
I Badirou, M Kurdi, P Legendre, J Rayes, M Bryckaert, C Casari, PJ Lenting, OD Christophe, CV Denis, T Miyata
PloS one 2012
The Tn Antigen-Structural Simplicity and Biological Complexity
T Ju, VI Otto, RD Cummings
Angewandte Chemie (International ed. in English) 2011
Das Tn-Antigen - strukturell einfach und biologisch komplex
T Ju, VI Otto, RD Cummings
Angewandte Chemie 2011
The plasma von Willebrand factorO-glycome comprises a surprising variety of structures including ABH antigens and disialosyl motifs
K Canis, TA Mckinnon, A Nowak, M Panico, HR Morris, M Laffan, A Dell
Journal of Thrombosis and Haemostasis 2010
A comparison of nano-electrospray gas-phase electrophoretic mobility macromolecular analysis and matrix-assisted laser desorption/ionization linear time-of-flight mass spectrometry for the characterization of the recombinant coagulation glycoprotein von Willebrand factor
J Kemptner, M Marchetti-Deschmann, R Müller, A Ivens, P Turecek, HP Schwarz, G Allmaier
Rapid Communications in Mass Spectrometry 2010
Factor VIII and von Willebrand factor - too sweet for their own good
PJ Lenting, JN Pegon, OD Christophe, CV Denis
Haemophilia 2010
Recent Advances in Thrombosis and Hemostasis 2008
K Tanaka, EW Davie, Y Ikeda, S Iwanaga, H Saito, K Sueishi
2008
Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival
SL Haberichter, M Balistreri, P Christopherson, P Morateck, S Gavazova, DB Bellissimo, MJ Manco-Johnson, JC Gill, RR Montgomery
Blood 2006
ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?
PV Jenkins, JS O?Donnell
Transfusion 2006
O-Linked glycosylation and functional incompatibility of porcine von Willebrand factor for human platelet GPIb receptors
JS Esch, SC Robson, WT Knoefel, SB Hosch, X Rogiers
Xenotransplantation 2005
Impact ofO-linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction
JS Esch, SC Robson, WT Knoefel, CF Eisenberger, M Peiper, X Rogiers
British Journal of Haematology 2005
Impact of O -linked glycosylation of the VWF-A1-domain flanking regions on platelet interaction
JS Esch, SC Robson, WT Knoefel, CF Eisenberger, M Peiper, X Rogiers
British Journal of Haematology 2005
Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells
SL Haberichter, EP Merricks, SA Fahs, PA Christopherson, TC Nichols, RR Montgomery
Blood 2005
Critical independent regions in the VWF propeptide and mature VWF that enable normal VWF storage
SL Haberichter, P Jacobi, RR Montgomery
Blood 2003
Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands
LG Ellies, D Ditto, GG Levy, M Wahrenbrock, D Ginsburg, A Varki, DT Le, JD Marth
Proceedings of the National Academy of Sciences 2002
Role of A and B blood group antigens in the expression of adhesive activity of von Willebrand factor
R Sarode, J Goldstein, II Sussman, RL Nagel, HM Tsai
British Journal of Haematology 2000
Von Willebrand factor storage and multimerization: 2 independent intracellular processes
SL Haberichter, SA Fahs, RR Montgomery
Blood 2000
Recombinant von Willebrand factor: potential therapeutic use
B E Fischer
Journal of Thrombosis and Thrombolysis 1999
von Willebrand disease: Pathogenesis, classification, and management
EW Murray, D Lillicrap
Transfusion Medicine Reviews 1996
EFFECT OF MULTIMERIZATION OF HUMAN AND RECOMBINANT VON WILLEBRAND FACTOR ON PLATELET AGGREGATION, BINDING TO COLLAGEN AND BINDING OF COAGULATION FACTOR VIII
BE Fischer, G Kramer, A Mitterer, L Grillberger, M Reiter, W Mundt, F Dorner, J Eibl
Thrombosis Research 1996
Promotion of binding of von Willebrand factor to platelet glycoprotein Ib by dimers of ristocetin
MF Hoylaerts, K Nuyts, K Peerlinck, H Deckmyn, J Vermylen
Biochemical Journal 1995
Purification and characterization of human platelet von Willebrand factor
SB Williams, LP McKeown, H Krutzsch, K Hansmann, HR Gralnick
British Journal of Haematology 1994
The interaction of the von Willebrand factor-A1 domain with platelet glycoprotein Ib/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein
MA Cruz, RI Handin, RJ Wise
The Journal of biological chemistry 1993

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
20 readers on Mendeley
See more details